Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Circulating Biomarkers May Predict Who Will Have a Stroke

By LabMedica International staff writers
Posted on 07 Sep 2016
People with high levels of four biomarkers in the blood may be more likely to develop an ischemic stroke (IIS) than people with low levels of the biomarkers.

Adding these four biomarkers to an existing method of predicting a person's stroke risk based on factors such as age, sex, cholesterol and blood pressure, called the Framingham Stroke Risk Profile, improved the ability to predict who would develop a stroke.

A team of scientists led by those at McMaster University (Hamilton, ON, Canada) measured the levels of 15 biomarkers associated with inflammation in the blood of people from the Framingham Heart Study Offspring Cohort who had never had a stroke. More...
The 3,224 participants had a mean age of 61 ± 9, with 54% of them female, at the start of the study and were followed for an average of nine year and during that time, and 98 people had a stroke.

Of the 15 biomarkers, four were associated with an increased risk of stroke. People with elevated homocysteine (tHcy) were 32% more likely to have a stroke. Those with high vascular endothelial growth factor (VEGF) were 25% more likely; those with high C-reactive protein (CRP) were 28% more likely; and those with high ln-tumor necrosis factor receptor 2 (TNFR2) were 33% more likely to have a stroke during the study.

Ashkan Shoamanesh, MD, the lead author of the study, said, “"Identifying people who are at risk for stroke can help us determine who would benefit most from existing or new therapies to prevent stroke. The study shows a relationship between high levels of the biomarkers and stroke; it does not establish that the high levels cause stroke.” He also noted that the biomarkers were measured only once and the investigators did not account for infections, chronic diseases or other conditions that could have affected the results. The study was published on August 24, 2016, in the journal Neurology.

Related Links:
McMaster University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.